– 2020, a record year with revenue of €13.5m, up 51% on 2019
– 2020 results in line with expectations
– Acceleration of the growth dynamic in the first quarter of 2021 with revenue of €5.2m, an increase of 86% compared to Q1, 2020
Median Technologies announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on March 9th, 2021 at 11:30 am CET during a webcast.
Read moreThese two appointments follow a series of first successful achievements for iBiopsy® in 2020 and early 2021. Median prepares to launch its iBiopsy® product development plan, including regulatory aspects, define its go-to-market strategy then expand its iBiopsy® operations globally.
Read moreMedian is building a cloud based end-to-end approach performing both localization and discrimination of malignant and benign lung lesions. The company plans to demonstrate the potential of deep learning models to increase the accuracy, consistency and adoption of lung cancer screening worldwide. First results for a proof of concept on a cohort of 1,800 patients are expected in H2, 2021.
Read moreTo download this content please complete the form below
[contact-form-7 id="5108" title="Download file form"]